Among the infants classified as underweight, 47.2% had wasting and 52.8% had stunting, based on the study’s complementary anthropometric assessments. By comparison, 7.3% of infants who were not underweight had wasting and 10.5% had stunting. These results show that a weight-for-age z score of at least −2 did not exclude other anthropometric deficits among the comparison group. The investigators therefore described WAZ-defined underweight separately from the complementary assessments rather than treating the measures as interchangeable. Prematurity, small-for-gestational-age status and a low-intake flag were associated with underweight at admission.

Clinical outcomes were ascertained for 628 infants. Readmission occurred in 42.3% of infants who were underweight, compared with 22.0% of the comparison group. Transplantation or death occurred in 14.1% and 4.9%, respectively, in the two groups. A complete-case Cox regression analysis of the 18-month composite outcome included 593 infants and 183 events. Admission underweight was associated with the composite outcome, with an adjusted hazard ratio of 1.70 and a 95% confidence interval of 1.22–2.37. This estimate represents the association remaining after adjustment for variables included in the model; it does not demonstrate that underweight itself produced the higher event hazard.

Growth measurements added a more qualified result. Among 96 initially underweight infants with paired measurements, mean WAZ increased by 1.58 units. The authors cautioned that this observed improvement was subject to regression to the mean and selective follow-up, and that much of the recorded morbidity was prevalent at admission or had an uncertain onset. The retrospective design further limits the ability to determine when growth deficits developed or to separate the effects of nutritional status from other clinical differences. Taken together, the findings identify admission underweight as a marker associated with greater healthcare use and adverse clinical outcomes, while also showing why a single weight-for-age classification does not capture the full range of anthropometric deficits in infants with cholestasis.

Subject of Research: Association of admission underweight with clinical outcomes in infants with cholestasis

Article Title: Admission weight-for-age defined underweight and 18-month clinical outcomes in infants with cholestasis: a five-year retrospective cohort study

Article References: Li, S., Wei, H., Liu, X., He, F., Zhao, Y., & Wang, L. (2026). Admission weight-for-age defined underweight and 18-month clinical outcomes in infants with cholestasis: a five-year retrospective cohort study. BMC Pediatrics. https://doi.org/10.1186/s12887-026-07883-3

Image Credits: AI Generated

DOI: 10.1186/s12887-026-07883-3

Keywords: infantile cholestasis, underweight, weight-for-age z score, wasting, stunting, hospital readmission, liver transplantation, 18-month outcomes, retrospective cohort, anthropometry, Admission, weight-for-age

Researchers led by Mouad Elganga, a medical student at the Temerty Faculty of Medicine at the University of Toronto, pooled evidence from 38 studies encompassing 7,507 patients to determine whether mobile app-based home monitoring improved recovery after surgery. The answer was nuanced. Patients enrolled in app-based monitoring programs had a 22 percent lower risk of major postoperative complications and a 22 percent lower risk of emergency room visits compared with those receiving standard postoperative care. Hospital readmissions fell by 15 percent. Yet the technology itself was not the active ingredient: readmissions dropped only in programs where a physician, surgeon or nurse actually reviewed the information patients submitted and could intervene when warning signs appeared. Programs that collected data without clinician review showed no reduction in readmissions at all.

The programs varied considerably in design, but most shared a common architecture. Patients completed daily check-ins on a smartphone or web portal, reporting symptoms such as pain, fever, nausea and the appearance of their surgical wounds. Some programs layered in wearable fitness trackers or Bluetooth-enabled devices, including blood pressure cuffs, thermometers and pulse oximeters that measure blood oxygen levels. This stream of patient-generated data, in principle, gives surgical teams a continuous window into recovery that traditional follow-up, typically a single office visit one to two weeks after discharge, simply cannot provide.

Elganga emphasized that the app alone is not a safety net. “Just using an app may not make recovery safer,” he said. “The biggest benefit occurs when a clinician is actually reviewing what patients send and can act on it. Patients should ask: ‘Who is looking at this information, how quickly will they respond and what happens if something looks wrong?'” The framing is a practical one for patients navigating an increasingly digital health care landscape, where remote monitoring offerings are proliferating faster than the evidence base can evaluate them.

One finding deserves particular scrutiny. The total number of complications did not significantly decline across the pooled studies, which suggests that app-based monitoring may not prevent postoperative problems from arising in the first place. What it appears to do is catch concerning symptoms before they escalate into major complications requiring emergency care, intensive care admission, readmission, an additional procedure or reoperation. In other words, the intervention seems to function less as a shield and more as an early warning system, converting problems that would have surfaced in the emergency department into issues that can be addressed with a phone call, a prescription adjustment or an earlier clinic visit.

The patient experience data adds an important dimension to the clinical outcomes. Patients in the monitoring programs reported less pain and anxiety, better physical function, improved quality of life and greater satisfaction with their care. That combination is notable because pain and anxiety after discharge are not merely comfort issues; uncontrolled pain can limit mobility, which in turn raises the risk of blood clots and pulmonary complications, while anxiety can deter patients from reporting symptoms that matter. A monitoring system that reassures patients while keeping clinicians informed may reinforce recovery along several pathways at once.

The vulnerable window the research targets is well understood in surgical care. Complications such as surgical site infections, bleeding, blood clots and opioid-related adverse events often emerge in the first days to weeks after discharge, precisely when the intensity of clinical oversight falls off sharply. Traditional postoperative care typically consists of discharge instructions, a phone number to call and a scheduled follow-up appointment, leaving patients and families to interpret symptoms on their own. Remote monitoring attempts to extend the hospital’s surveillance reach into the home, and the pooled evidence now suggests that this extension can measurably reduce serious outcomes when it is coupled with clinical responsiveness.

For health systems weighing an investment in app-based monitoring, the findings point to a clear implementation principle: the technology is only as valuable as the clinical workflow built around it. The authors suggest that systems considering such programs should focus not only on the software and devices but also on ensuring that clinicians review patient-submitted information and respond promptly to concerning symptoms. That means staffing, protocols and response-time commitments, not just an app download at discharge. Programs that treat monitoring as a data collection exercise, without a human loop that can act on the data, appear to deliver little measurable benefit.

Patients, too, have a role in making these programs work. The researchers recommend that patients ask who is monitoring the information they submit and what the protocol is if something looks wrong. When a clinician is actively reviewing the data, using the app consistently, completing daily check-ins even on good days, may help the care team identify problems before they become emergencies. Consistency matters because intermittent reporting creates blind spots in exactly the period when complications are most likely to develop.

The research was presented at the ANESTHESIOLOGY 2026 annual meeting, and the society notes that meeting news releases may contain updated data that was not originally available at the time abstracts were submitted. As with any pooled analysis presented at a scientific meeting, the findings await the full scrutiny of peer review and publication, and the heterogeneity of the 38 included programs, from simple symptom check-ins to multi-device remote monitoring, means the results should be interpreted as a broad signal rather than a prescription for any single app. Still, the central message is likely to shape how hospitals design postoperative care in the years ahead: remote monitoring can make the transition from hospital to home safer, but the clinician reviewing the data, not the technology collecting it, is what makes the difference.

Subject of Research: A pooled analysis of 38 studies presented at the ANESTHESIOLOGY 2026 annual meeting found that mobile app-based postoperative monitoring was associated with fewer serious complications, emergency room visits and readmissions, with benefits dependent on clinician review of patient-submitted data.

Article Title: Mobile app monitoring may reduce serious complications after surgery, new study finds

Article References: Mobile app monitoring may reduce serious complications after surgery, new study finds. Original publication (Bibliographic details unavailable.)

Image Credits: AI Generated

DOI: Not provided

Keywords: postoperative care, remote patient monitoring, mobile health apps, surgical complications, hospital readmission, ANESTHESIOLOGY 2026, patient safety, telemedicine, Mobile, monitoring, reduce, serious

The research team, led by investigators at Rutgers School of Public Health and Columbia University, focused on four of the most serious bacterial infections associated with injection drug use: skin and soft tissue infections, osteomyelitis, infective endocarditis, and central nervous system abscesses. These conditions represent a spectrum of severity, from painful tissue infections that may require surgical drainage to life-threatening heart valve infections and brain abscesses that demand weeks of intravenous antibiotics. All of them share a common thread in the context of the ongoing drug overdose crisis, in which contaminated injection practices introduce bacteria into the bloodstream and deep tissues, creating infections that frequently require prolonged hospitalization.

Methodologically, the study is a retrospective cohort analysis designed to produce nationally representative estimates. The researchers applied survey weights to the Nationwide Readmission Database, a federal dataset that captures readmissions across state lines and allows analysts to track patients who move between hospitals, a critical feature given that many patients with substance use disorders receive care at multiple institutions. After weighting, the analysis encompassed 392,984 index admissions of adults hospitalized with a primary diagnosis of one of the four target infections. Each admission was classified into one of four exposure groups based on ICD-10-CM diagnostic codes: neither disorder, opioid use disorder only, stimulant use disorder only, or co-occurring opioid and stimulant use disorders.

The demographic profile of the cohort underscores how deeply these infections intersect with an aging population of people who inject drugs. The mean age of hospitalized patients was 58.8 years, 57.1 percent were male, and 46.9 percent carried Medicare coverage, a striking figure for a population often assumed to be younger and uninsured. Within the cohort, 4.5 percent of admissions involved opioid use disorder alone, 3.9 percent involved stimulant use disorder alone, and 2.4 percent involved both disorders simultaneously. The overall unplanned readmission rates were 4.3 percent within seven days of discharge and 12.48 percent within thirty days, meaning roughly one in eight patients returned to the hospital within a month of being sent home.

After statistical adjustment for patient and hospital characteristics, the central finding emerged clearly: having opioid use disorder, stimulant use disorder, or both was associated with higher odds of both seven-day and thirty-day unplanned all-cause readmission compared with patients who had neither disorder. This pattern held across the short and slightly longer follow-up windows, suggesting that the elevated risk is not confined to the immediate post-discharge period but persists through the first month, when patients are typically transitioning from intravenous antibiotics in the hospital to oral regimens or outpatient infusion therapy.

Perhaps the most clinically provocative result concerns the co-occurring group. Patients diagnosed with both opioid and stimulant use disorders showed higher odds of readmission than those with opioid use disorder alone, although the authors note that this particular comparison did not reach statistical significance in their models. The direction of the effect is nonetheless consistent with a growing body of literature on polysubstance use, which suggests that people who use multiple drug classes experience compounded medical and social vulnerabilities. Stimulants such as methamphetamine and cocaine can drive frequent injection episodes, cardiovascular strain, and erratic engagement with care, while opioids contribute to overdose risk and withdrawal-related treatment disruption. When both disorders are present, the pathways back to the hospital may multiply.

The mechanisms behind these associations are likely multifactorial, and the study’s design cannot fully disentangle them. Patients with untreated opioid use disorder may leave the hospital against medical advice to avoid withdrawal, cutting short antibiotic courses for infections like endocarditis that require weeks of therapy. Others may be discharged without linkage to medications for opioid use disorder such as buprenorphine or methadone, returning to injection practices that seed new infections at old or new sites. Social factors, including housing instability, lack of transportation to follow-up appointments, and stigma within healthcare settings, can compound the pharmacological challenges. Readmissions in this population may also reflect non-infectious causes, including withdrawal, overdose, and complications of untreated chronic disease, since the study measured all-cause readmission rather than infection-specific recurrence.

For the authors, the implications point squarely toward integrating addiction treatment into inpatient infection care. Hospitalization for a serious bacterial infection represents a rare moment of sustained contact between this population and the healthcare system, often the longest period of stability a patient experiences in months. Evidence from other fields suggests that initiating medications for opioid use disorder during hospital admission, combined with warm handoffs to community-based treatment, can reduce subsequent opioid use and improve retention in care. The new findings extend the logic to infectious diseases practice, where hospitals have historically treated the infection and discharged the patient without addressing the underlying substance use disorder that produced it.

The study carries important caveats that shape how its results should be interpreted. Diagnostic codes for substance use disorders depend on clinician documentation, and undercoding is common, particularly for stimulant use disorder, which may mean some exposed patients were misclassified as unexposed and the true associations could be stronger than estimated. The all-cause readmission outcome cannot distinguish between returns driven by infection relapse and those driven by other acute events. As with any database study, residual confounding by severity of illness, social determinants of health, and treatment intensity remains possible. The authors also relied on the 2022 database year, and patterns of drug use and hospital practice continue to evolve rapidly, meaning the estimates represent a snapshot of a dynamic epidemic.

Even with those limitations, the scale of the analysis gives its central message considerable weight. Nearly 400,000 weighted hospitalizations for injection-related bacterial infections in a single year, with one in eight patients readmitted within thirty days, describes an enormous and largely preventable burden on patients, families, and the healthcare system. The finding that opioid and stimulant use disorders independently elevate short-term readmission risk reframes these disorders not as peripheral social issues but as central clinical drivers of infectious disease outcomes. As the authors conclude, embedding addiction medicine within inpatient infectious disease care, from bedside initiation of treatment to structured post-discharge linkage, could transform the hospital stay from a revolving door into a genuine turning point for one of the most vulnerable populations in American medicine.

Subject of Research: The association between opioid and stimulant use disorders and unplanned hospital readmission after injection drug use-related bacterial infections

Article Title: The impact of co-occurring opioid and stimulant use disorders on unplanned readmissions among patients hospitalized with bacterial infections

Article References: Hu, J., Blair, N., Mauro, P. M., Samples, H., Bushnell, G., Yin, M. T., & Shiau, S. (2026). The impact of co-occurring opioid and stimulant use disorders on unplanned readmissions among patients hospitalized with bacterial infections. BMC Infectious Diseases. https://doi.org/10.1186/s12879-026-14321-3

Image Credits: AI Generated

DOI: 10.1186/s12879-026-14321-3

Keywords: opioid use disorder, stimulant use disorder, bacterial infection, hospital readmission, injection drug use, infective endocarditis, osteomyelitis, polysubstance use, addiction treatment, Nationwide Readmission Database, infectious diseases, public health

The study drew on administrative claims data spanning 2014 to 2022 from a large commercial insurer, giving the team an unusually rich window into who these patients are and how they interact with the health system. To qualify as high-need, high-cost, beneficiaries had to sit in the top 5 percent of healthcare spending in the prior year and be projected to remain there in the following year — a definition that captures people with complex, expensive, and often unstable medical lives. The intervention itself was a randomized controlled trial registered as NCT04415515, in which registered nurses attempted telephone outreach to coordinate care for these vulnerable patients. Because the program was national in scope, the researchers could probe whether geography, insurance plan design, and clinical history shaped the odds of contact and engagement.

The statistical machinery behind the analysis was deliberately twofold. The team used multivariate linear regression alongside lasso regression, a machine-learning technique that shrinks the coefficients of weak predictors toward zero and thereby isolates the variables that genuinely matter. Lasso regression also allowed the investigators to test two-way combinations of variables — interactions such as whether a particular comorbidity mattered more in one age group or region than another — which traditional models often miss. The predictors fed into the models included age, sex, geographic region, plan type, duration of enrollment in the insurance plan, a catalogue of comorbid conditions, and whether the patient had been hospitalized or treated in an emergency department in the three months before randomization.

One of the most counterintuitive findings concerns age. Younger beneficiaries were harder to contact and harder to engage than older ones, a pattern that inverts the common assumption that digital-native, working-age adults would be the easiest to pull into a phone-based program. The authors suggest that younger high-cost patients may be balancing employment, caregiving, and other demands that make unsolicited phone calls easy to ignore, or may simply be less receptive to a healthcare system reaching out by telephone. Whatever the mechanism, the implication is clear: a one-size-fits-all outreach script will leave younger complex patients behind.

Recent hospitalization told an equally striking story. Beneficiaries who had an inpatient admission within three months before randomization were more difficult to contact and engage, despite being, on paper, among the patients with the most obvious need for coordinated follow-up care. Hospital discharge is a chaotic moment — recovery at home, new medication regimens, follow-up appointments, and often lingering symptoms — and the study suggests that a nurse’s phone call can get lost in that turbulence. Longer duration of plan enrollment also predicted worse contact and engagement, hinting that patients with long, complicated insurance histories may have developed skepticism toward outreach efforts or accumulated administrative barriers that newer enrollees lack.

Comorbidity profiles painted a nuanced picture of who picks up the phone. Arthritis, HIV, and osteoporosis were each associated with successful contact, while congestive heart failure and substance abuse predicted less successful contact, as did living in the northeastern United States. When it came to actual engagement — completing at least one care coordination activity — arthritis, chronic obstructive pulmonary disease, and liver disease were associated with success. The divergence between the contact and engagement predictors is itself informative: the conditions that help a nurse reach a patient are not necessarily the ones that help that patient commit to the program. Regional variation also matters, and the authors note that the northeast’s lower contact rates may reflect anything from local phone habits to differences in healthcare infrastructure across states.

The lasso regression added a layer of granularity that the headline numbers conceal. Certain two-way variable-level combinations — specific pairings of characteristics such as a comorbidity crossed with a demographic or plan feature — emerged as predictors of engagement, suggesting that the pathways into care coordination are not uniform but instead depend on how a patient’s attributes interact. For program designers, this is both a warning and an opportunity. It warns that aggregate statistics can mask subgroups of patients who are systematically missed, and it offers a roadmap: predictive models trained on claims data could flag, in advance, which beneficiaries are least likely to answer or engage, allowing outreach teams to tailor their approach before the first call is ever placed.

The scale of the gap is worth dwelling on. If 41 percent of the highest-cost, highest-need patients in a national program cannot be reached at all, and nearly half of those reached never complete a single coordination activity, then the effective reach of the intervention shrinks to roughly 28 percent of the intended population. Every unreached patient represents missed opportunities: unmanaged medication conflicts, duplicated tests, avoidable emergency department visits, and preventable readmissions. Care coordination programs have shown promise in reducing costs and improving outcomes for complex populations, but this study demonstrates that their success is gated at the very first step — the human act of answering a phone call and agreeing to a conversation.

The authors conclude that recruitment and engagement of high-need, high-cost patients must be tailored rather than uniform, and their predictor catalogue offers a concrete starting point for that tailoring. Outreach strategies might need to differ for younger patients, for those recently discharged from the hospital, for people with substance abuse or heart failure, and for residents of particular regions — perhaps through multiple contact channels, different timing, or trusted messengers beyond the standard nurse call. The study was supported by a cooperative agreement from the Centers for Disease Control and Prevention, and while the findings and conclusions are those of the authors, their implications ripple across insurers, policymakers, and health systems nationwide. As healthcare continues to pour resources into managing its most expensive patients, this research delivers a blunt message: before any intervention can work, someone has to pick up the phone — and far too many of the people who need it most never do.

Subject of Research: Predictors of patient contact and engagement in a national telephone-based care coordination intervention for high-need, high-cost health insurance beneficiaries

Article Title: Predictors of contact and engagement in a national care coordination intervention for high-need, high-cost beneficiaries

Article References: Fatehpuria, A., Harwood, J. M., Tseng, C.-H., Duru, O. K., Mangione, C. M., Onufrak, S. J., & Moin, T. (2026). Predictors of contact and engagement in a national care coordination intervention for high-need, high-cost beneficiaries. BMC Health Services Research. https://doi.org/10.1186/s12913-026-15662-0

Image Credits: AI Generated

DOI: 10.1186/s12913-026-15662-0

Keywords: care coordination, high-need high-cost patients, patient engagement, telephone intervention, health services research, predictive factors, randomized controlled trial, lasso regression, chronic disease, health insurance, hospital readmission, CDC

The starting point for the correspondence is a 2025 study by Campbell and colleagues, also published in the Journal of General Internal Medicine, which examined the impact of substance use navigators on two outcomes of obvious clinical and economic importance: initiation of treatment for substance use disorders and 30-day unplanned hospital readmission. Navigators in such models typically meet patients during or shortly after an emergency department visit, establish rapport, address practical barriers such as insurance, transportation, and appointment scheduling, and maintain follow-up contact until the patient is connected with medication for opioid use disorder, counseling, or other formal treatment. The Campbell study reported on the program’s overall effect, and the new letter by Luo and Song accepts the value of that contribution while arguing that the field now needs to ask finer-grained questions about mechanism and equity.

The first of those questions concerns dose-response. In epidemiology and clinical research, a dose-response relationship describes how an outcome changes as the level of exposure increases—in this case, how the number, duration, or intensity of navigator interactions relates to the probability that a patient initiates treatment or avoids an early readmission. Luo and Song argue that establishing such a relationship matters for more than statistical completeness. If treatment initiation rises steadily with each additional navigator contact, that pattern would support a causal interpretation of the navigator’s role and would give program designers an empirical basis for setting contact targets. If instead the relationship plateaus or is non-linear, with most benefit accruing in the first few encounters, health systems could allocate scarce navigator time more efficiently, concentrating intensive outreach on the patients who need it rather than spreading effort uniformly.

The letter situates this argument within modern causal thinking. Luo and Song cite work by Shimonovich and colleagues in the European Journal of Epidemiology that revisits the classic Bradford Hill considerations for assessing causality in epidemiology in light of contemporary developments in causal inference. That framework emphasizes that consistency, biological or mechanistic plausibility, and dose-response gradients are suggestive but not decisive on their own, and that observational findings must be interpreted with explicit attention to confounding and selection. Applied to navigator research, the implication is that a simple before-and-after comparison of treatment initiation rates cannot settle whether navigators caused the improvement, because patients who receive more navigator contact may differ systematically from those who receive less—in motivation, housing stability, insurance status, or severity of illness. Dose-response analysis, the letter suggests, is one tool among several for strengthening causal interpretation, provided it is designed with those confounders in view.

The second axis of the letter concerns socioeconomic factors. Luo and Song highlight that the effectiveness of a navigator program cannot be fully understood without attending to the social and economic circumstances of the patients it serves. Substance use disorders are strongly patterned by socioeconomic position: housing instability, unemployment, low educational attainment, lack of insurance, and limited access to transportation all raise the barriers between a patient in an emergency department and a functioning treatment linkage. A navigator intervention that appears uniformly effective in an aggregate analysis may in fact work well for some patient subgroups and poorly for others, and the letter argues that exploring these heterogeneities is essential both for scientific understanding and for equitable program design.

Support for this concern comes from a broader literature that the letter references. Birkeland and colleagues, writing in Addiction Science and Clinical Practice, examined perceived family cohesion, social support, and quality of life among patients undergoing treatment for substance use disorders, comparing them with patients treated for mental and physical disorders. Their findings underscore that social resources are not peripheral to addiction treatment but intertwined with how patients experience and sustain it. For navigators, this literature suggests that the same dose of navigator contact may translate into different outcomes depending on the family, community, and economic context surrounding each patient. A patient with stable housing and supportive family members may need relatively brief navigation to reach treatment, while a patient facing homelessness or isolation may require sustained, resource-intensive engagement that standard program protocols were not designed to provide.

The practical implications of the letter’s argument extend to how navigator programs are evaluated. Randomized trials and quasi-experimental studies of navigation have generally reported average effects across enrolled populations, and those averages have informed decisions by hospital systems and policymakers. Luo and Song’s point is that averages can conceal the dose-response structure and the socioeconomic gradient that actually determine a program’s real-world performance. An evaluation that records the number and duration of navigator contacts, stratifies outcomes by measures of socioeconomic position, and models the interaction between the two would give administrators actionable information: which patients to prioritize, how many contacts to budget for, and where supplementary social services—housing assistance, benefits enrollment, peer support—would complement navigation most effectively.

The letter also speaks to a tension familiar in implementation science: the trade-off between fidelity to a tested model and adaptation to local conditions. Navigator programs originated in cancer care and have been adapted for HIV, mental health, and substance use, with each adaptation altering the intensity and scope of the role. If dose-response analysis shows that early contacts carry most of the benefit, programs might reasonably front-load engagement in the first days after an emergency visit. If socioeconomic stratification shows that disadvantaged patients derive equal or greater benefit from extended navigation, then uniform staffing models that cap contact time may systematically underserve the patients with the greatest need. In either scenario, the letter’s framework converts a general endorsement of navigation into specific, testable design parameters.

It is worth noting the limits of what the letter itself establishes. As a correspondence item, it does not present new patient data, and its authors report no funding and declare no conflicts of interest. Its contribution is to set an agenda: future studies of substance use navigators, the authors argue, should be designed from the outset to capture contact intensity and socioeconomic context, rather than treating navigation as an undifferentiated exposure. The citation of Bradford Hill–informed causal reasoning signals that the authors want the field to move beyond association toward defensible causal claims, using designs such as stratified analyses, sensitivity analyses for unmeasured confounding, and, where feasible, randomized variation in navigator dosage.

For clinicians and health system leaders, the message is that the navigator model has earned its place in the response to substance use disorders, but that its next phase of development depends on finer measurement. The questions Luo and Song raise—how much contact is enough, for whom, and under what social conditions—are precisely the questions that determine whether navigation becomes a durable, scalable component of addiction care or a promising intervention whose benefits erode as it spreads. The letter, published as part of the Journal of General Internal Medicine’s correspondence section, is likely to shape the design of the next generation of navigator evaluations, and its emphasis on dose and equity reflects a broader shift in health services research toward understanding not just whether interventions work, but how and for whom.

Subject of Research: Dose-response relationships and socioeconomic factors in substance use navigator programs for addiction treatment linkage

Article Title: Enhancing the Impact of Substance Use Navigators: Exploring Dose-Response Relationships and Socioeconomic Factors

Article References: Luo, J., & Song, Y. (2026). Enhancing the Impact of Substance Use Navigators: Exploring Dose-Response Relationships and Socioeconomic Factors. Journal of General Internal Medicine. https://doi.org/10.1007/s11606-026-10813-9

Image Credits: AI Generated

DOI: 10.1007/s11606-026-10813-9

Keywords: substance use navigators, dose-response, socioeconomic factors, emergency department, treatment initiation, hospital readmission, causal inference, Bradford Hill, health equity, addiction medicine, Journal of General Internal Medicine, implementation science

The scale of that figure becomes clearer when placed in context: $441 million approaches nearly twelve percent of the proposed fiscal year 2027 budget for the National Heart, Lung, and Blood Institute, the federal agency that funds much of the nation’s cardiovascular research. In other words, the money currently absorbed by preventable postoperative infections in a single insurance program rivals a substantial share of what the country invests in studying heart disease itself. The researchers argue that this gap represents not an intractable clinical challenge but a national opportunity to improve recovery and lower costs simultaneously.

To reach these conclusions, the team examined Medicare claims from nearly 240,000 cardiac surgery procedures carried out at approximately 1,000 hospitals between 2018 and 2023. Claims data allowed the investigators to track which patients were diagnosed with, and treated for, different categories of infection during the 180 days following their operations. This window matters because the danger of infection after cardiac surgery does not end at hospital discharge. About one in five patients develops an infection in the months following the procedure, with urinary tract infections, pneumonia, and sepsis among the most common complications. Sepsis, the body’s runaway inflammatory response to infection, is particularly consequential, since it can cascade into organ dysfunction and prolonged intensive care.

The study’s central finding is the sheer width of the variation. Hospitals in the highest infection group experienced more than twice as many infections as the best-performing institutions, a difference that persisted after the researchers statistically adjusted for differences in the patients each hospital treated and the procedures each performed. That adjustment is critical, because it addresses the most common objection to hospital comparisons: that some centers simply take on sicker, higher-risk patients. The persistence of the gap suggests that institutional factors, including surgical technique, perioperative protocols, antibiotic timing, wound care practices, and post-discharge monitoring, play a decisive role in outcomes.

The consequences of elevated infection rates ripple well beyond the infections themselves. Hospitals with higher infection rates also recorded higher rates of stroke, hospital readmission, and death up to six months after surgery. The financial toll was equally striking: procedures performed at hospitals in the highest infection group were associated with nearly $16,000 more in Medicare spending during the six months after surgery than identical procedures performed at hospitals in the lowest infection group. That figure captures not only the direct cost of treating infections but the downstream expenses of extended admissions, additional procedures, rehabilitation, and repeat hospitalizations that complications set in motion.

Using benchmark modeling, a technique that projects what would happen if all institutions performed at the level of the top performers, the research team estimated the national savings potential. Bringing hospitals with average and high infection rates in line with the best performers could prevent about 2,600 infections per year and reduce annual Medicare spending by as much as $441 million. Benchmarking of this kind is widely used in quality improvement research because it frames performance gaps not as a criticism of individual hospitals but as a measurable, addressable distance between current practice and demonstrated best practice.

One of the study’s more sobering discoveries concerns where these infections are actually detected. More than one-quarter of postsurgical infections were identified when patients were readmitted to a hospital different from the one where their surgery took place. The researchers point to this pattern as evidence of fragmented care. When patients receive follow-up treatment across multiple healthcare systems, their complete medical history may not travel with them, making complications harder to prevent, recognize, and manage in time. An infection brewing in a surgical wound may be caught late, or its early warning signs may be missed entirely by clinicians who did not perform the original operation and lack access to its details.

The findings echo earlier work by some members of the same research group. A previous study found that better care coordination for patients undergoing coronary artery bypass grafting, the heart bypass operation commonly known as CABG, could save an estimated $130 million annually in hospital readmission costs alone. Taken together, the two studies sketch a consistent picture: the recovery period after cardiac surgery is a vulnerable interval in which the quality of transitions between hospitals, clinics, and home care determines both patient outcomes and financial costs. Co-senior author Donald S. Likosky, the Richard and Norma Sarns Research Professor in Michigan Medicine’s Department of Cardiac Surgery, emphasized that a combination of hospital-based prevention strategies and effective transitions of care throughout the recovery period is needed to close the gap.

Co-senior author Francis Pagani, the Otto Gago MD Endowed Professor in Cardiac Surgery at the University of Michigan Medical School, framed the variation as a roadmap rather than an indictment. By understanding where practice patterns differ, he noted, researchers can better identify what drives the best outcomes and apply those approaches more broadly, providing consistent, high-quality care for every patient regardless of which hospital they enter. Co-first author Ahmad M. Hider, a National Clinician Scholar at the University of Michigan Institute for Healthcare Policy and Innovation and a general surgery resident at the University of Colorado, described reducing infections after cardiac surgery as a national opportunity to improve recovery and lower Medicare spending, underscoring the need to understand why some hospitals achieve better results and how best practices can be disseminated across the country.

The study was supported by the Agency for Healthcare Research and Quality, and the authors acknowledged the support of the Michigan Society of Thoracic and Cardiovascular Surgeons Quality Collaborative along with Blue Cross and Blue Shield of Michigan and Blue Care Network, which participate in the BCBSM Value Partnerships program. Additional contributors included co-first author Reem Nasser, a University of Michigan undergraduate and member of Michigan Medicine’s Undergraduate Research Academy, along with Chiang-Hua Chang, Shiwei Zhou, Thomas M. Braun, Robert B. Hawkins, Geoffrey D. Barnes, Michael P. Thompson, Timothy C. Guetterman of the University of Michigan, and Russell J. Funk of the University of Minnesota. As an observational study, the analysis identifies associations rather than proving causation, and the authors note that their conclusions do not reflect the views of AHRQ or the Department of Health and Human Services. Still, the message for patients, clinicians, and policymakers is difficult to ignore: the difference between a smooth recovery and a complicated one after heart surgery may depend as much on where the operation is performed and how care is coordinated afterward as on the surgery itself.

Subject of Research: Hospital variation in postoperative infections and Medicare spending after cardiac surgery in the United States

Article Title: Reducing infections after heart surgery could save Medicare $441 million per year

Article References: Reducing infections after heart surgery could save Medicare $441 million per year. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: cardiac surgery, postoperative infection, Medicare spending, hospital quality variation, sepsis, pneumonia, care coordination, hospital readmission, benchmarking, health policy, coronary artery bypass grafting, patient outcomes

The study, published in BMC Geriatrics by researchers affiliated with Örebro University and Region Örebro County, took advantage of a natural experiment in Swedish primary care. Between November 2016 and May 2019, a single primary health care centre in Örebro County implemented the Safe homecoming intervention, a structured program in which physicians, nurses, occupational therapists, and other professionals work together to plan and deliver tailored home health care for older patients in the immediate aftermath of a hospital stay. The intervention is deliberately time-limited and interprofessional, designed to catch avoidable complications early, coordinate medication management, and ensure that the transition from hospital to home does not leave patients falling through the cracks between specialist and primary care. Until now, however, the program had never been formally evaluated, leaving its designers without scientific evidence of whether it actually changed outcomes.

To fill that gap, the research team led by Ulrika Westerling assembled an unusually large comparison framework. Drawing on administrative registers and medical records spanning 2013 to 2020, they identified a source cohort of 38,338 patients aged 75 or older who had been hospitalized for at least one day in Örebro County. From this pool, 128 patients who had received the Safe homecoming intervention at the participating centre were matched, using propensity scores, to 512 controls from across the county who received standard care. Propensity score matching is a statistical technique that pairs treated and untreated patients on the basis of observed characteristics, in this case variables such as age, sex, comorbidity burden measured by the weighted Charlson Comorbidity Index, medication use classified by the Anatomical Therapeutic Chemical system, and diagnostic history coded under ICD-10. The goal is to make the two groups as comparable as possible, mimicking the balance of a randomized trial even though patients were not randomly assigned.

The matching appears to have worked well. The mean age in both groups was 85.5 years, and 60.9 percent of patients in each group were women, reflecting the demographics of the very old hospital population in Sweden. Standardized mean differences, the metric researchers use to quantify balance between matched groups, were used to confirm that the intervention and control patients were comparable on the measured covariates. Still, the authors are careful to note the inherent limits of observational designs: patients who received the intervention may have differed from controls in ways the registers could not capture, such as functional status, social support, or the simple fact of being enrolled at a primary care centre motivated enough to run an innovative program. These unmeasured differences, known as residual confounding, always loom over propensity score studies.

The headline result concerns readmissions. At 90 days after discharge, the cumulative incidence of a first hospital readmission was 20.3 percent in the intervention group compared with 33.6 percent among controls, a difference the authors tested with Gray’s test, yielding a p-value of 0.005. In plain terms, roughly one in five older patients who received Safe homecoming ended up back in the hospital within three months, versus one in three of those receiving usual care. Because death is a competing event that precludes readmission, the team employed the statistical machinery of competing-risk analysis, calculating Fine-Gray subdistribution hazard ratios that account for the fact that some patients died before they could be readmitted. The resulting subdistribution hazard ratio at 90 days was 0.57, with a 95 percent confidence interval of 0.37 to 0.86 and a p-value of 0.008, indicating a statistically significant reduction in readmission risk of roughly 43 percent. A parallel cause-specific Cox model, which treats deaths as censoring events rather than competing risks, produced a nearly identical hazard ratio of 0.55, with a confidence interval of 0.36 to 0.84.

The picture changes, however, when the follow-up window stretches to a full year. At 365 days, the Fine-Gray estimate was 0.79, with a confidence interval of 0.59 to 1.05 and a p-value of 0.098, a result that just misses conventional thresholds for statistical significance and suggests the intervention’s protective effect may fade over time. This pattern is biologically plausible. Transitional care interventions are, by design, time-limited; once the intensive home visits and coordinated planning end, older patients return to the same baseline risks of disease progression, frailty, and acute illness that precipitated their original hospitalization. The intervention may succeed at preventing the avoidable complications of a poorly managed discharge, but it cannot permanently insulate patients from the chronic conditions that put them in the hospital in the first place.

Mortality tells a more equivocal story. Across all the follow-up time points the researchers evaluated, the mortality estimates numerically favoured the intervention group, hinting that Safe homecoming might also be associated with longer survival. But the confidence intervals at every time point included the null value of one, meaning the observed differences could easily have arisen by chance. With only 128 patients in the intervention arm, the study simply lacked the statistical power to detect anything but a very large effect on death. The authors are explicit on this point: there is no clear evidence of an association between the intervention and mortality, and the numerical trend should be read as hypothesis-generating rather than confirmatory.

The study’s limitations deserve as much attention as its findings. Beyond the small intervention sample and the retrospective design, the researchers evaluated multiple follow-up time points, which raises the possibility that at least one of the reported results could reflect chance variation across the many analyses performed. The single-centre nature of the intervention also raises questions about generalizability; Safe homecoming was delivered by one primary health care centre with a particular team and a particular patient population, and other settings might implement the model differently or serve patients with different needs. The authors themselves conclude that the findings should be considered exploratory and require confirmation in larger prospective studies, ideally randomized trials that can eliminate confounding altogether and enroll enough patients to detect effects on mortality as well as readmission.

Even with those caveats, the study arrives at a moment when health systems across the high-income world are grappling with the twin pressures of aging populations and strained hospital capacity. Readmissions among older adults are enormously costly, both in financial terms and in the toll they take on patients, for whom each hospitalization brings risks of delirium, functional decline, and loss of independence. If a structured, interprofessional home care program delivered through ordinary primary care can cut 90-day readmissions by more than 40 percent, the potential public health payoff is substantial, particularly in countries like Sweden where primary health care centres already serve as the backbone of the system. The Swedish model examined here, which builds on coordinated individual planning and leverages existing primary care infrastructure rather than requiring new institutions, could be relatively straightforward to scale, though the authors’ call for larger prospective studies makes clear that the evidence is not yet strong enough to justify wholesale adoption. What the study does establish is a rigorous, registry-based template for evaluating such programs, one that other regions could replicate as they experiment with their own versions of a safer homecoming.

Subject of Research: Effects of a transitional home care intervention on mortality and hospital readmission among older adults after hospital discharge

Article Title: Safe homecoming intervention after hospital discharge: a retrospective cohort study of mortality and readmission among patients 75 years or older in Sweden

Article References: Westerling, U., Taj, T., Nilsing Strid, E., Hermansson, L., & Hellgren, M. (2026). Safe homecoming intervention after hospital discharge: a retrospective cohort study of mortality and readmission among patients 75 years or older in Sweden. BMC Geriatrics. https://doi.org/10.1186/s12877-026-08367-w

Image Credits: AI Generated

DOI: 10.1186/s12877-026-08367-w

Keywords: transitional care, older adults, hospital readmission, primary health care, propensity score matching, competing-risk analysis, geriatrics, home health care, Sweden, mortality, frail elderly, continuity of care

The study, published in BMC Medicine by Niping Qin of the First Hospital of Shanxi Medical University, Zhiping Yang, Daiming Fan, and colleagues, analyzed inpatient electronic health records from 2018 to 2022. The team identified 2,042,063 hospital admissions involving multimorbidity, defined as the co-occurrence of at least two chronic physical conditions. That enormous sample gave the investigators statistical power to detect subtle differences in how combinations of diseases behave once patients enter the hospital. Rather than treating each condition as an independent item on a checklist, the researchers built a multimorbidity network in which diseases were nodes and statistically significant co-occurrence links were edges. The finished network contained 304 nodes and 2,513 edges, a dense web of clinical associations spanning the full spectrum of chronic medicine.

The structural analysis relied on the Louvain modularity algorithm, a widely used community-detection method borrowed from network science. The algorithm partitions a graph by iteratively moving nodes between groups to maximize modularity, a measure of how densely connected nodes are within communities relative to connections between them. In this clinical context, the method grouped diseases that tend to travel together in the same patients. Nine distinct disease communities emerged from the analysis. Hypertension, type 2 diabetes, and stroke occupied central hub positions in the network, meaning they were connected to an unusually large number of other conditions and likely serve as physiological gateways through which other chronic diseases cluster. That finding aligns with decades of epidemiology showing that metabolic and vascular disease drives much of the multimorbidity burden in aging populations.

With the network communities defined, the team turned to prediction. They fitted three nested regression models for three outcomes that matter enormously to hospital administrators and patients alike: length of stay, total hospitalization cost, and the risk of readmission within 30 days of discharge. The first model adjusted for demographic factors alone. The second added the ACCI. The third added the multimorbidity network patterns on top of the conventional score. Model fit was compared using the Akaike information criterion and the Bayesian information criterion, standard penalized likelihood measures that reward explanatory power while discouraging overfitting. Across all three outcomes, adding the network patterns produced reductions in both AIC and BIC, indicating that the community structure carried genuine predictive information that the ACCI does not capture.

The clinical texture of the results is where the study becomes most striking. Community 6, a cluster the authors characterize as endocrine-immune-renal diseases, carried the highest readmission risk of any pattern, with an odds ratio of 1.591. Yet admissions in that community were associated with lower total costs, at a mean ratio of 0.696 relative to the reference. Community 8, a cardiovascular-arrhythmic cluster, showed the opposite profile: shorter lengths of stay, with a rate ratio of 0.691, and markedly lower readmission risk, with an odds ratio of 0.478. These are not the kinds of signals a weighted point count can produce. Two patients with identical ACCI scores could sit in entirely different network communities and face dramatically different probabilities of bouncing back through the emergency department within a month.

To quantify how much each ingredient contributed at the population level, the researchers used counterfactual predictions, estimating what outcomes would have looked like if a given risk factor were removed. The ACCI accounted for 25.21 percent of the population-level attribution for readmission risk, a substantial share that confirms the old score still earns its place. But the multimorbidity patterns showed considerable variability in their risk contributions, with some communities contributing far more than others. In other words, the network approach does not replace the Charlson Index; it layers a structural dimension on top of it, capturing the architecture of disease co-occurrence that a scalar score flattens away.

Why should the arrangement of diseases matter as much as their presence? The answer likely lies in shared pathophysiology and shared care pathways. A patient whose conditions cluster in the endocrine-immune-renal community may face cascading metabolic and immunologic instability, polypharmacy across multiple specialties, and fragmented follow-up, all of which raise the odds of readmission. A patient in the cardiovascular-arrhythmic community, by contrast, may benefit from well-established, protocolized cardiac care that resolves the acute episode efficiently. Network communities, in this reading, are proxies for the coherence of a patient’s clinical story. When diseases share mechanisms, they also share treatments, prognoses, and failure modes, and the network makes that shared structure visible in a way that additive scoring cannot.

The scale of the dataset is central to the study’s credibility. Multimorbidity research is notoriously difficult because any individual combination of conditions becomes vanishingly rare in small samples, forcing investigators to collapse diseases into crude categories. With more than two million admissions drawn from every tertiary hospital in a single Chinese province over five years, the Shanxi cohort allowed the network to be built from robust co-occurrence estimates and the outcome models to be adjusted for demographics and the ACCI simultaneously. The retrospective design, however, carries familiar caveats. Electronic health record data reflect coding practices that vary across institutions, and observational associations cannot establish that reshaping a patient’s disease community would change their outcomes. The authors are careful to frame the findings as improved explanation and risk stratification rather than causal proof.

The practical implications reach into hospital management as much as bedside medicine. Readmission within 30 days is a universally watched quality metric, and hospitals face financial penalties for excess readmissions in several health systems. If a simple derivation of a patient’s network community, computable from routine diagnosis codes at admission, flags the endocrine-immune-renal pattern as high risk, discharge planners could target enhanced follow-up, medication reconciliation, and early outpatient contact toward that group. Conversely, the shorter stays and lower readmission risk associated with the cardiovascular-arrhythmic community suggest that resource allocation calibrated to disease clusters, rather than to raw comorbidity counts, could direct scarce transitional-care resources where they matter most. The authors suggest the approach could inform more tailored clinical management and more rational allocation of hospital resources.

The study also lands at a moment when network medicine is maturing from an elegant theoretical framework into a practical clinical tool. The same community-detection mathematics that maps protein interactions and social graphs is increasingly applied to diagnosis co-occurrence, drug repurposing, and now inpatient outcomes. What this analysis demonstrates is that the incremental value is measurable and meaningful even against a benchmark as entrenched as the Charlson Index. As health systems worldwide grapple with aging populations in which multimorbidity is the norm rather than the exception, the question is shifting from whether patients have multiple diseases to how those diseases are wired together. On the evidence of two million admissions, the wiring diagram may be one of the most informative things a hospital record contains.

Subject of Research: Multimorbidity network patterns and their predictive value for inpatient outcomes compared with conventional comorbidity indices

Article Title: Multimorbidity network patterns improve the explanation of inpatient outcomes beyond conventional comorbidity assessment: a retrospective cohort study across 32 tertiary hospitals

Article References: Qin, N., Xu, J., Wang, X., Wang, Y., Jin, Z., Zheng, J., Li, L., Li, J., Yang, Z., & Fan, D. (2026). Multimorbidity network patterns improve the explanation of inpatient outcomes beyond conventional comorbidity assessment: a retrospective cohort study across 32 tertiary hospitals. BMC Medicine. https://doi.org/10.1186/s12916-026-05264-2

Image Credits: AI Generated

DOI: 10.1186/s12916-026-05264-2

Keywords: multimorbidity, comorbidity, Charlson Comorbidity Index, network analysis, hospital readmission, length of stay, hospitalization cost, electronic health records, Louvain algorithm, risk stratification, BMC Medicine, retrospective cohort study

Researchers led by Jorge Maese-Calvo of Fundación COMPUTAEX, together with clinicians and investigators across Spain’s Extremadura region, have developed an interpretable machine learning approach that predicts whether an individual heart failure patient will be readmitted within 30 days of discharge. Their work, published in Medical & Biological Engineering & Computing, draws on a remarkable asset: a population-based registry covering two decades of heart failure hospitalizations in a rural Spanish healthcare setting. The registry, spanning the years 2000 to 2019, includes nearly 5,000 admissions and had never before been used for artificial intelligence modeling, making it a uniquely grounded testing ground for predictive algorithms in an underserved population.

The scale of the problem the team tackled is hard to overstate. Heart failure affects an estimated 64 million people worldwide, and its prevalence continues to climb as populations age. In the Spanish cohort studied, 8.2 percent of patients were readmitted within 30 days of discharge. While that figure may sound modest, each readmission represents a clinical setback for the patient, a financial burden for the health system, and a missed opportunity for the kind of targeted post-discharge support that could have kept the person at home. Hospital systems in the United States and Europe have introduced penalty and incentive programs around readmission rates, but risk stratification at the moment of discharge remains crude, often relying on clinicians’ intuition or simple scoring rules that capture only part of the picture.

The researchers’ strategy was deliberately pragmatic. Rather than demanding exotic biomarkers or data types that rural hospitals cannot easily collect, they built their models from routinely gathered clinical variables: demographic details, laboratory values, comorbidities, admission characteristics, and length of stay. Three machine learning algorithms were trained and compared against conventional binary logistic regression, the statistical workhorse that has historically served as the default for clinical risk prediction. The contenders were a random forest, an ensemble method that aggregates hundreds of decision trees; extreme gradient boosting, known as XGBoost, which builds trees sequentially to correct earlier errors; and a support vector machine, which finds optimal boundaries separating patient groups in high-dimensional space.

The results were clear. The random forest model emerged as the strongest performer, achieving an area under the receiver operating characteristic curve, or AUC, of 0.812, with a 95 percent confidence interval of 0.744 to 0.867. An AUC of 0.5 indicates performance no better than a coin flip, while 1.0 represents perfect discrimination; a value above 0.80 reflects clinically useful discrimination. By contrast, binary logistic regression managed an AUC of 0.686, with a confidence interval of 0.617 to 0.755. The gap matters because clinical prediction is unforgiving: a model that merely matches traditional statistics offers no reason to change practice, but a model that meaningfully outperforms it can reshape how discharge decisions are made. The advantage of tree-based ensembles lies in their ability to capture nonlinear relationships and interactions between variables, such as the way renal dysfunction may amplify risk differently depending on a patient’s age or prior cardiac history, relationships that rigid regression forms can miss.

What distinguishes this study from many AI-in-medicine efforts is its insistence on interpretability. Black-box models have faced justified skepticism from clinicians who need to understand why an algorithm flags a particular patient as high risk before acting on that information. To open the box, the team applied SHAP, or SHapley Additive exPlanations, a technique borrowed from cooperative game theory that assigns each predictor a quantified contribution to every individual prediction. SHAP values reveal not only which variables matter most overall but also the direction and consistency of their effects, exposing whether, for instance, longer hospital stays push risk up or down across the cohort or whether the relationship shifts in different patient subgroups. This transparency, the authors argue, is what transforms a prediction from an oracle’s pronouncement into a clinical instrument.

The SHAP analysis identified a compact set of dominant predictors. The period in which the patient was admitted emerged as influential, reflecting how the clinical profile and outcomes of heart failure hospitalizations evolved across the two decades covered by the registry, as treatment practices and diagnostic standards changed. Markers of renal dysfunction ranked among the strongest signals, consistent with a growing body of evidence linking impaired kidney function to heart failure readmissions; the cardiorenal interplay means that failing kidneys often herald decompensating hearts. A history of prior heart failure, older age, and longer length of hospital stay completed the top tier of predictors. Each of these is available to clinicians before discharge, which means the model’s inputs place no new burden on resource-constrained rural facilities.

The implications reach beyond the algorithm’s raw performance. In rural health systems, where access to cardiologists, structured follow-up clinics, and home-monitoring programs is often limited, every intervention dollar must be spent where it counts. A transparent risk score computed at discharge could direct scarce resources, such as early nurse visits, telemonitoring enrollment, or expedited outpatient appointments, toward the patients most likely to return. Because the model explains itself, a hospitalist in a small regional hospital could see that a particular patient’s risk is driven chiefly by declining renal markers and a prior heart failure admission, and tailor the discharge plan accordingly. The study was supported by Spain’s Ministry of Science and Innovation through the Complementary Plan for Applied Biotechnology in Health, backed by Next Generation EU funds, reflecting a broader European push to bring precision medicine tools into everyday care.

The authors are careful about what their results do and do not establish. The model was trained and validated within a single regional registry, and its performance in other populations, health systems, and countries remains to be demonstrated. External validation in independent cohorts and prospective evaluation of real-world impact, measuring whether the model actually reduces readmissions when deployed at the bedside, are required before clinical implementation. The underlying data are not publicly available due to privacy and ethical restrictions, though access may be considered with appropriate approvals. These caveats are standard in the field, and the study’s methodology aligns with emerging international guidance such as the TRIPOD+AI reporting framework and the FUTURE-AI consensus on trustworthy clinical artificial intelligence, both of which emphasize rigorous validation, transparency, and fairness. Even with those limitations, the work represents a meaningful step forward. It demonstrates that interpretable machine learning, fed by the ordinary data that any hospital already collects, can outperform traditional statistical models and deliver predictions clinicians can actually understand. For rural communities bearing a disproportionate share of the heart failure burden, that combination of accuracy, accessibility, and transparency could prove decisive in keeping vulnerable patients from cycling back through hospital doors.

Subject of Research: Interpretable machine learning prediction of 30-day readmission after heart failure hospitalization using a 20-year rural population registry

Article Title: Predicting 30-day readmission after heart failure hospitalization using interpretable machine learning: evidence from a 20-year population-based rural registry

Article References: Maese-Calvo, J., Paredes-Calderón, A., Nunez-Bayon, M., Arévalo-Lorido, J. C., Mayoral-Testón, N., Nevado-Nogales, C., José Zaro-Bastanzuri, M., González-Fernández, R., Hernández-Rollán, N., Corral-García, J., Rico-Gallego, J. A., & Fernández-Bergés, D. (2026). Predicting 30-day readmission after heart failure hospitalization using interpretable machine learning: evidence from a 20-year population-based rural registry. Medical & Biological Engineering & Computing. https://doi.org/10.1007/s11517-026-03657-2

Image Credits: AI Generated

DOI: 10.1007/s11517-026-03657-2

Keywords: heart failure, hospital readmission, machine learning, random forest, XGBoost, SHAP, interpretable AI, rural health, renal dysfunction, clinical decision support, risk prediction, registry study